Oberweis Asset Management Inc Neogenomics Inc Transaction History

Oberweis Asset Management Inc

$2.02 Billion
Q4 2024

A detailed history of Oberweis Asset Management Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Oberweis Asset Management Inc holds 768,700 shares of NEO stock, worth $8.36 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

768,700

Previous 718,700 6.96%

Holding current value

$8.36 Million

Previous $10.6 Million 19.51%

% of portfolio

0.63%

Previous 0.57%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$13.0 - $18.43 $650,000 - $921,500	50,000 Added 6.96%	768,700 $12.7 Million
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $670,000 - $886,500	50,000 Added 7.48%	718,700 $10.6 Million
Q2 2024 Aug 14, 2024	SELL	$13.01 - $15.77 $891,185 - $1.08 Million	-68,500 Reduced 9.29%	668,700 $9.27 Million
Q1 2024 May 15, 2024	BUY	$14.06 - $16.79 $4.84 Million - $5.78 Million	344,500 Added 87.73%	737,200 $11.6 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $1.16 Million - $2.06 Million	99,300 Added 33.84%	392,700 $6.35 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $976,860 - $1.44 Million	80,400 Added 37.75%	293,400 $3.61 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $3 Million - $4.22 Million	213,000 New	213,000 $3.42 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $330,776 - $453,952	-17,300 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$19.57 - $24.1 $455,981 - $561,530	-23,300 Reduced 57.39%	17,300 $380,000
Q1 2019 May 15, 2019	SELL	$12.14 - $20.46 $292,574 - $493,086	-24,100 Reduced 37.25%	40,600 $831,000
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $727,228 - $1.2 Million	64,700 New	64,700 $816,000

Others Institutions Holding NEO

# of Institutions

282

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.37B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oberweis Asset Management Inc with notifications on news.

Account

Oberweis Asset Management Inc Neogenomics Inc Transaction History